Regulation of in vitro insulin release from a transplantable Syrian hamster insulinoma

S. Shapiro, S. Eto, N. Fleischer, Stephen G. Baum

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

An insulin producing islet cell tumor of the Syrian hamster has been studied in vitro for its capacity to respond to known stimuli of insulin release. Insulin secretion during short term incubation and perifusion of fragments of tumor was detected by radioimmunoassay. Insulin release was increased 2-4 fold by 40 mM potassium in the presence of calcium, glucose (22 mM), glucagon (0.3-3.0 μM), N*'O2' dibutyryl adenosine 3',5' monophosphate (cAMP; 6 mM), and theophylline (10 mM). Concentrations of glucagon that induced insulin release were also effective in activating adenylate cyclase in the membranes of tumor cells. Thus, this tumor appears to possess a cAMP mediated mechanism for insulin release. Somatostatin (0.8-25 μm) inhibited glucagon induced insulin release without altering basal or glucagon stimulated adenylate cyclase activity. It would appear that inhibition of glucagon induced insulin release by somatostatin is not mediated by adenylate cyclase. It is proposed that insulin release by this tumor is sufficiently similar to that found in normal islets so as to make it a suitable model for biochemical studies that require large quantities of homogeneous tissue.

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalEndocrinology
Volume97
Issue number2
StatePublished - 1975

Fingerprint

Insulinoma
Mesocricetus
Insulin
Glucagon
Adenylyl Cyclases
Neoplasms
Islet Cell Adenoma
In Vitro Techniques
Bucladesine
Theophylline
Somatostatin
Radioimmunoassay
Potassium
Cell Membrane
Calcium
Glucose

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Regulation of in vitro insulin release from a transplantable Syrian hamster insulinoma. / Shapiro, S.; Eto, S.; Fleischer, N.; Baum, Stephen G.

In: Endocrinology, Vol. 97, No. 2, 1975, p. 442-447.

Research output: Contribution to journalArticle

Shapiro, S. ; Eto, S. ; Fleischer, N. ; Baum, Stephen G. / Regulation of in vitro insulin release from a transplantable Syrian hamster insulinoma. In: Endocrinology. 1975 ; Vol. 97, No. 2. pp. 442-447.
@article{b4cc88c92afb4bb3818e437be60af845,
title = "Regulation of in vitro insulin release from a transplantable Syrian hamster insulinoma",
abstract = "An insulin producing islet cell tumor of the Syrian hamster has been studied in vitro for its capacity to respond to known stimuli of insulin release. Insulin secretion during short term incubation and perifusion of fragments of tumor was detected by radioimmunoassay. Insulin release was increased 2-4 fold by 40 mM potassium in the presence of calcium, glucose (22 mM), glucagon (0.3-3.0 μM), N*'O2' dibutyryl adenosine 3',5' monophosphate (cAMP; 6 mM), and theophylline (10 mM). Concentrations of glucagon that induced insulin release were also effective in activating adenylate cyclase in the membranes of tumor cells. Thus, this tumor appears to possess a cAMP mediated mechanism for insulin release. Somatostatin (0.8-25 μm) inhibited glucagon induced insulin release without altering basal or glucagon stimulated adenylate cyclase activity. It would appear that inhibition of glucagon induced insulin release by somatostatin is not mediated by adenylate cyclase. It is proposed that insulin release by this tumor is sufficiently similar to that found in normal islets so as to make it a suitable model for biochemical studies that require large quantities of homogeneous tissue.",
author = "S. Shapiro and S. Eto and N. Fleischer and Baum, {Stephen G.}",
year = "1975",
language = "English (US)",
volume = "97",
pages = "442--447",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Regulation of in vitro insulin release from a transplantable Syrian hamster insulinoma

AU - Shapiro, S.

AU - Eto, S.

AU - Fleischer, N.

AU - Baum, Stephen G.

PY - 1975

Y1 - 1975

N2 - An insulin producing islet cell tumor of the Syrian hamster has been studied in vitro for its capacity to respond to known stimuli of insulin release. Insulin secretion during short term incubation and perifusion of fragments of tumor was detected by radioimmunoassay. Insulin release was increased 2-4 fold by 40 mM potassium in the presence of calcium, glucose (22 mM), glucagon (0.3-3.0 μM), N*'O2' dibutyryl adenosine 3',5' monophosphate (cAMP; 6 mM), and theophylline (10 mM). Concentrations of glucagon that induced insulin release were also effective in activating adenylate cyclase in the membranes of tumor cells. Thus, this tumor appears to possess a cAMP mediated mechanism for insulin release. Somatostatin (0.8-25 μm) inhibited glucagon induced insulin release without altering basal or glucagon stimulated adenylate cyclase activity. It would appear that inhibition of glucagon induced insulin release by somatostatin is not mediated by adenylate cyclase. It is proposed that insulin release by this tumor is sufficiently similar to that found in normal islets so as to make it a suitable model for biochemical studies that require large quantities of homogeneous tissue.

AB - An insulin producing islet cell tumor of the Syrian hamster has been studied in vitro for its capacity to respond to known stimuli of insulin release. Insulin secretion during short term incubation and perifusion of fragments of tumor was detected by radioimmunoassay. Insulin release was increased 2-4 fold by 40 mM potassium in the presence of calcium, glucose (22 mM), glucagon (0.3-3.0 μM), N*'O2' dibutyryl adenosine 3',5' monophosphate (cAMP; 6 mM), and theophylline (10 mM). Concentrations of glucagon that induced insulin release were also effective in activating adenylate cyclase in the membranes of tumor cells. Thus, this tumor appears to possess a cAMP mediated mechanism for insulin release. Somatostatin (0.8-25 μm) inhibited glucagon induced insulin release without altering basal or glucagon stimulated adenylate cyclase activity. It would appear that inhibition of glucagon induced insulin release by somatostatin is not mediated by adenylate cyclase. It is proposed that insulin release by this tumor is sufficiently similar to that found in normal islets so as to make it a suitable model for biochemical studies that require large quantities of homogeneous tissue.

UR - http://www.scopus.com/inward/record.url?scp=0016800371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016800371&partnerID=8YFLogxK

M3 - Article

C2 - 169125

AN - SCOPUS:0016800371

VL - 97

SP - 442

EP - 447

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -